Details for Patent: 7,700,645

« Back to Dashboard

Which drugs does patent 7,700,645 protect, and when does it expire?

Patent 7,700,645 protects SYMTUZA, PREZISTA, and PREZCOBIX, and is included in four NDAs.

Protection for PREZISTA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-eight patent family members in twenty-five countries.

Summary for Patent: 7,700,645

Title:	Pseudopolymorphic forms of a HIV protease inhibitor
Abstract:	New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
Inventor(s):	Hans Wim Pieter Vermeersch, Daniel Joseph Christiaan Thoné, Luc Donné Marie-Louise Janssens
Assignee:	Janssen Sciences Ireland ULC
Application Number:	US10/514,352
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,700,645
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 7,700,645

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Janssen Prods	SYMTUZA	cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate	TABLET;ORAL	210455-001	Jul 17, 2018		RX	Yes	Yes	7,700,645		Y	Y
Janssen Prods	PREZISTA	darunavir	SUSPENSION;ORAL	202895-001	Dec 16, 2011		RX	Yes	Yes	7,700,645*PED				Y
Janssen Prods	PREZCOBIX	cobicistat; darunavir ethanolate	TABLET;ORAL	205395-002	Mar 21, 2025		RX	Yes	Yes	7,700,645*PED				Y
Janssen Prods	PREZCOBIX	cobicistat; darunavir ethanolate	TABLET;ORAL	205395-001	Jan 29, 2015		RX	Yes	Yes	7,700,645*PED				Y
Janssen Prods	PREZISTA	darunavir	TABLET;ORAL	021976-004	Dec 18, 2008	AB	RX	Yes	No	7,700,645*PED				Y
Janssen Prods	PREZISTA	darunavir	TABLET;ORAL	021976-005	Dec 18, 2008	AB	RX	Yes	No	7,700,645*PED				Y

Foreign Priority and PCT Information for Patent: 7,700,645

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	02076929	May 16, 2002

PCT Information
PCT Filed	May 16, 2003	PCT Application Number:	PCT/EP03/50176
PCT Publication Date:	December 24, 2003	PCT Publication Number:	WO03/106461

International Family Members for US Patent 7,700,645

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	2052
Australia	2003271740
Australia	2012205289
Brazil	0311176
Brazil	PI0311176
Canada	2485834